Fineline Cube

Follow:
14778 Articles
BioAge Labs and Novartis Partner to Discover Aging-Related Therapeutic Targets
CompanyDeals

BioAge Labs and Novartis Partner to Discover Aging-Related Therapeutic Targets

DaAn Gene Co., Ltd Receives NMPA Approval for Genetic Deafness Gene Detection Kit
CompanyMedical Device

DaAn Gene Co., Ltd Receives NMPA Approval for Genetic Deafness Gene Detection Kit

MediLink Therapeutics' YL201 Receives FDA Orphan Drug Designation for Small-Cell Lung Cancer
CompanyDrug

MediLink Therapeutics’ YL201 Receives FDA Orphan Drug Designation for Small-Cell Lung Cancer

BMS Regains Exclusive Rights to ABZ-706 in Greater China
CompanyDeals

BMS Regains Exclusive Rights to ABZ-706 in Greater China

Everest Medicines' Nefecon Receives First Prescription for IgAN Treatment in Adults
CompanyDrug

Everest Medicines’ Nefecon Receives First Prescription for IgAN Treatment in Adults

FDA Approves Xcovery Holdings' Ensartinib for Untreated ALK-Positive NSCLC Patients
CompanyDrug

FDA Approves Xcovery Holdings’ Ensartinib for Untreated ALK-Positive NSCLC Patients

NT Medical Instruments to Acquire Controlling Stake in Weiqiang Medical Technology for RMB 230 Million
CompanyDeals

INT Medical Instruments to Acquire Controlling Stake in Weiqiang Medical Technology for RMB 230 Million

Janssen-Cilag Submits for IMBRUVICA Indication Extension in Untreated Mantle Cell Lymphoma
CompanyDrug

Janssen-Cilag Submits for IMBRUVICA Indication Extension in Untreated Mantle Cell Lymphoma

iFlytek's Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million
CompanyDeals

iFlytek’s Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million

Chengdu Kanghua Biological Receives NMPA Approval for Recombinant Norovirus Vaccine
CompanyDrug

Chengdu Kanghua Biological Receives NMPA Approval for Recombinant Norovirus Vaccine

Sinocare Inc's TRUE VIE CGMS Advances to 510(k) Substantive Review Stage at FDA
CompanyMedical Device

Sinocare Inc’s TRUE VIE CGMS Advances to 510(k) Substantive Review Stage at FDA

Huadong Medicine's HDM1005 Receives FDA Clearance for Heart Failure and Obesity Clinical Trial
CompanyDrug

Huadong Medicine’s HDM1005 Receives FDA Clearance for Heart Failure and Obesity Clinical Trial